Suche
Mein Konto
Medicinal supply in Germany: facts instead of rumors
The current press release from the AOK (WIDO) scientific institute provides positive news about the supply of drugs in Germany. Despite media reports on possible bottlenecks, 98.8 percent of the medication are available. The AOK CEO Dr. Carola Reimann emphasizes that the discount contracts of the health insurance companies contribute to high security security. Learn more about the actual situation of the availability of drugs and the necessary measures to improve transparency.
Medicinal supply in Germany: facts instead of rumors
The pharmaceutical supply is under the burning glass! Carola Reimann, the CEO of the AOK federal association, clear words. In today's press release from the AOK scientific institute (Wido), it is loudly announced: There are no signs of impending bottlenecks!
Autumn has come, and while the news about scarce fever juices and other potentially vital drugs are piling up, the current data situation for all doubters brings a refreshing truth to light. 98.8 percent of all medications are still available! This is not just a number, that is a sign of the security of supply of an incredible 99.9 percent!
The exposing of the myths
But what causes all the excitement? The emotions are understandable, says Reimann. But they calm down when you take a look at the facts. Again and again the discussion about discount contracts by the health insurance companies shadows the care discussion. Here the finger is placed on the wrong wound. These discount contracts ensure medication!
The reality is that they oblige manufacturers to plan their stock better and make the sales in a comprehensible manner. It is the lack of transparency that makes the whole situation critical. While we can easily track a package with socks these days, there is no similar documentation for the availability of medicinal products in the entire supply chain. This is a nightmare for patient safety!
The current discussion about delivery difficulties in saline solution - a product that does not require any discount contracts is particularly absurd! Here the discussion is turned upside down!
Reimann calls for an urgent regulation, to create transparency in pharmaceutical supply . This is the only way to avoid real bottlenecks in the future!
Important note for all media: The comprehensive analysis of the supply situation for medicinal products from the wido is a must for every editorial office!